Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 2/20 | 0.44 |
| ▸ | KDR | P35968 | 9/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 8/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 4/20 | 0.43 |
| ▸ | TLK2 | Q86UE8 | 3/20 | 0.43 |
| ▸ | FLT3 | P36888 | 6/20 | 0.42 |
| ▸ | FLT1 | P17948 | 3/20 | 0.41 |
| ▸ | CSF1R | P07333 | 2/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.41 |
| ▸ | KIT | P10721 | 4/20 | 0.40 |
| ▸ | PIM1 | P11309 | 2/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | RIOK2 | Q9BVS4 | 2/20 | 0.40 |
| ▸ | TLK1 | Q9UKI8 | 2/20 | 0.40 |
| ▸ | PRKAA2 | P54646 | 2/20 | 0.40 |
| ▸ | PRKAA1 | Q13131 | 2/20 | 0.40 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.40 |
| ▸ | PLK4 | O00444 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2114261 | 0.91 | CCNB2 (0.42) | KDRPDGFRBFGFR1TLK2KIT | |
| SCHEMBL2116265 | 0.91 | PIM1 (0.39) | ALKKDRPDGFRBFGFR1FLT3 | |
| SCHEMBL2117620 | 0.90 | LRRK2 (0.40) | ALKKDRPDGFRBFGFR1TLK2 | |
| SCHEMBL2116293 | 0.87 | PDGFRB (0.43) | KDRPDGFRBFGFR1CHEK1EGFR | |
| SCHEMBL2115110 | 0.85 | KDR (0.42) | KDRPDGFRBFGFR1TLK2FLT3 | |
| SCHEMBL2116258 | 0.85 | CCNB2 (0.40) | ALKKDRPDGFRBFGFR1TLK2 | |
| SCHEMBL2117379 | 0.83 | KDR (0.42) | KDRPDGFRBFGFR1TLK2KIT | |
| SCHEMBL2118661 | 0.77 | KDR (0.41) | ALKKDRPDGFRBFGFR1TLK2 | |
| SCHEMBL2117534 | 0.76 | CCNB2 (0.42) | KDRPDGFRBFGFR1TLK2KIT | |
| SCHEMBL1673441 | 0.75 | ALK (0.52) | ALKKDRPDGFRBFGFR1TLK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120094998-A1 | Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates | NEKTAR THERAPEUTICS (US) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094998-A1 | Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates | PTK2B, ERBB2, FRK | ALK 191/4885KDR 395/4885PDGFRB 555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.